CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cells.

Autor: Rathore U; Gladstone Institutes, San Francisco, California, USA.; Department of Microbiology and Immunology, University of California, San Francisco, California, USA.; Innovative Genomics Institute, University of California, Berkeley, California, USA., Haas P; Gladstone Institutes, San Francisco, California, USA.; Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA., Easwar Kumar V; Gladstone Institutes, San Francisco, California, USA.; Department of Microbiology and Immunology, University of California, San Francisco, California, USA.; Innovative Genomics Institute, University of California, Berkeley, California, USA., Hiatt J; Gladstone Institutes, San Francisco, California, USA.; Department of Microbiology and Immunology, University of California, San Francisco, California, USA.; Innovative Genomics Institute, University of California, Berkeley, California, USA.; Medical Scientist Training Program, University of California, San Francisco, California, USA.; Biomedical Sciences Graduate Program, University of California, San Francisco, California, USA., Haas KM; Gladstone Institutes, San Francisco, California, USA.; Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA., Bouhaddou M; Gladstone Institutes, San Francisco, California, USA.; Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA., Swaney DL; Gladstone Institutes, San Francisco, California, USA.; Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA., Stevenson E; Gladstone Institutes, San Francisco, California, USA.; Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA., Zuliani-Alvarez L; Gladstone Institutes, San Francisco, California, USA.; Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA., McGregor MJ; Gladstone Institutes, San Francisco, California, USA.; Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA., Turner-Groth A; Gladstone Institutes, San Francisco, California, USA., Ochieng' Olwal C; West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.; Department of Biochemistry, Cell & Molecular Biology, College of Basic & Applied Sciences, University of Ghana, Accra, Ghana., Bediako Y; West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.; Department of Biochemistry, Cell & Molecular Biology, College of Basic & Applied Sciences, University of Ghana, Accra, Ghana., Braberg H; Gladstone Institutes, San Francisco, California, USA.; Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA., Soucheray M; Gladstone Institutes, San Francisco, California, USA.; Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA., Ott M; Gladstone Institutes, San Francisco, California, USA., Eckhardt M; Gladstone Institutes, San Francisco, California, USA.; Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA., Hultquist JF; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Center for Pathogen Genomics and Microbial Evolution, Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Marson A; Gladstone Institutes, San Francisco, California, USA.; Department of Microbiology and Immunology, University of California, San Francisco, California, USA.; Innovative Genomics Institute, University of California, Berkeley, California, USA.; Department of Medicine, University of California, San Francisco, California, USA.; Diabetes Center, University of California, San Francisco, California, USA.; UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, California, USA.; Institute for Human Genetics, University of California, San Francisco, California, USA., Kaake RM; Gladstone Institutes, San Francisco, California, USA.; Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA., Krogan NJ; Gladstone Institutes, San Francisco, California, USA.; Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA.

Publikováno v: MBio [mBio] 2024 Apr 10; Vol. 15 (4), pp. e0222223. Date of Electronic Publication: 2024 Feb 27.

Prior COVID‐19 infection among newly diagnosed tuberculosis patients in a tertiary care center in Tehran: A case‐control study.

Autor: Semnani, Kiavash¹ (AUTHOR), Sohrabi, Marjan² (AUTHOR), Alavijeh, Parvaneh Ebrahimi³ (AUTHOR), SeyedAlinaghi, SeyedAhmad⁴ (AUTHOR), Esmaeili, Shirin¹ (AUTHOR), Halabchi, Farzin⁵ (AUTHOR), Alizadeh, Zahra⁵ (AUTHOR), Salami, Amir⁶ (AUTHOR), Khaneshan, Arezoo Salami^2,4 (AUTHOR) arezoo.salami64@gmail.com

Publikováno v: Immunity, Inflammation & Disease. May2024, Vol. 12 Issue 5, p1-8. 8p.

Identifying the Interaction Between Tuberculosis and SARS-CoV-2 Infections via Bioinformatics Analysis and Machine Learning.

Autor: Huang, Ze-Min, Kang, Jia-Qi, Chen, Pei-Zhen, Deng, Lin-Fen, Li, Jia-Xin, He, Ying-Xin, Liang, Jie, Huang, Nan, Luo, Tian-Ye, Lan, Qi-Wen, Chen, Hao-Kai, Guo, Xu-Guang

Publikováno v: Biochemical Genetics; Aug2024, Vol. 62 Issue 4, p2606-2630, 25p

Review of Pediatric Tuberculosis in the Aftermath of COVID-19.

Autor: Rangchaikul, Patrida¹ (AUTHOR), Ahn, Phillip¹ (AUTHOR), Nguyen, Michelle¹ (AUTHOR), Zhong, Vivian¹ (AUTHOR), Venketaraman, Vishwanath¹ (AUTHOR) vvenketaraman@westernu.edu

Publikováno v: Clinics & Practice. Oct2022, Vol. 12 Issue 5, p738-754. 17p.

Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection.

Autor: Shah, Taif, Shah, Zahir, Yasmeen, Nafeesa, Baloch, Zulqarnain, Xia, Xueshan

Publikováno v: Frontiers in Immunology; 6/16/2022, Vol. 13, p1-17, 17p